Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  The Scotts Miracle-Gro Company    SMG

THE SCOTTS MIRACLE-GRO COMPANY

(SMG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

The Scotts Miracle-Gro Company : Good timing to anticipate a continuation of the trend

share with twitter share with LinkedIn share with facebook
07/31/2020 | 10:37am EDT
long trade on a pullback
On stand-by
Entry price : 151$ | Target : 177$ | Stop-loss : 139$ | Cancellation Level : 170$ | Potential : 17.22%
The timing appears opportune to go long in shares of The Scotts Miracle-Gro Company as we anticipate another pick-up in the underlying trend.
Investors should buy the stock at current prices near $ 151 in order to target the $ 177.
The Scotts Miracle-Gro Company : The Scotts Miracle-Gro Company : Good timing to anticipate a continuation of the trend
Summary
  • In a short-term perspective, the company has interesting fundamentals.
  • The Scotts Miracle-Gro Company accounts for 5.33 % of our USA Portfolio. A trade is currently open since 06/11/2020 with a purchase price of $ 137.99. Discover the other 19 stocks of the USA portfolio managed by the MarketScreener portfolio management team.

Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 117.78 USD

Weaknesses
  • The stock is close to a major daily resistance at USD 162.52, which should be gotten rid of so as to gain new appreciation potential.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Subsector Agricultural Chemicals - NEC
1st jan.Capitalization (M$)Investor Rating
THE SCOTTS MIRACLE-GRO COMP..49.34%8 801
SOCIEDAD QUÍMICA Y MINERA D..14.46%8 041
UPL LIMITED-18.18%4 877
ICL GROUP LTD-32.62%4 698
PHOSAGRO11.67%4 688
BAYER CROPSCIENCE LIMITED55.97%3 715
PI INDUSTRIES LIMITED21.61%3 564
OCI N.V.-46.61%2 482
XINYANGFENG AGRICULTURAL TE..45.57%2 185
COMPASS MINERALS INTERNATIO..-16.44%1 727
K+S AG-49.49%1 271
More Results

David Meurisse
© MarketScreener.com 2020
share with twitter share with LinkedIn share with facebook

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 4 035 M - -
Net income 2020 367 M - -
Net Debt 2020 1 663 M - -
P/E ratio 2020 24,1x
Yield 2020 1,49%
Capitalization 8 801 M 8 801 M -
EV / Sales 2020 2,59x
EV / Sales 2021 2,48x
Nbr of Employees 5 600
Free-Float 72,5%
Upcoming event on THE SCOTTS MIRACLE-GRO COM
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 162,17 $
Last Close Price 158,57 $
Spread / Highest target 23,0%
Spread / Average Target 2,27%
Spread / Lowest Target -17,4%
EPS Revisions
Managers
NameTitle
James Hagedorn Chairman & Chief Executive Officer
Michael C. Lukemire President & Chief Operating Officer
Thomas Randal Coleman CFO, Principal Accounting Officer & Executive VP
Dave Swihart Senior VP-Global Research & Development
Katherine Hagedorn Littlefield Vice Chairman